Özge Gümüşay

637 total citations · 1 hit paper
42 papers, 350 citations indexed

About

Özge Gümüşay is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Özge Gümüşay has authored 42 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Özge Gümüşay's work include Renal cell carcinoma treatment (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Diagnosis and Treatment (5 papers). Özge Gümüşay is often cited by papers focused on Renal cell carcinoma treatment (7 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Diagnosis and Treatment (5 papers). Özge Gümüşay collaborates with scholars based in Türkiye, United States and United Kingdom. Özge Gümüşay's co-authors include Hope S. Rugo, Laura A. Huppert, Bülent Çetin, Damé Idossa, Ahmet Özet, Süleyman Buyukberber, İpek Işık Gönül, Aytuğ Üner, Mustafa Beneklı and Uğur Çoşkun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and CA A Cancer Journal for Clinicians.

In The Last Decade

Özge Gümüşay

36 papers receiving 345 citations

Hit Papers

Systemic therapy for horm... 2023 2026 2024 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer
    2023 96 citations Laura A. Huppert, Özge Gümüşay et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özge Gümüşay Türkiye 11 164 124 100 78 33 42 350
Dilara Akhoundova Switzerland 12 247 1.5× 118 1.0× 148 1.5× 113 1.4× 28 0.8× 45 425
Karel Cwiertka Czechia 10 247 1.5× 123 1.0× 115 1.1× 108 1.4× 31 0.9× 45 436
Daniel P. Petro United States 11 243 1.5× 194 1.6× 188 1.9× 49 0.6× 54 1.6× 21 428
Samia Melaabi France 10 200 1.2× 166 1.3× 152 1.5× 199 2.6× 44 1.3× 22 456
Umair Majeed United States 5 149 0.9× 159 1.3× 95 0.9× 81 1.0× 16 0.5× 27 295
Christa G.M. Gadellaa-van Hooijdonk Netherlands 6 349 2.1× 121 1.0× 106 1.1× 141 1.8× 15 0.5× 7 506
Rodrigo Ruiz-Soto United States 9 186 1.1× 90 0.7× 174 1.7× 37 0.5× 36 1.1× 19 408
Lydia Koi Germany 10 144 0.9× 112 0.9× 154 1.5× 150 1.9× 20 0.6× 19 375
Lucia Raimondo Italy 8 185 1.1× 105 0.8× 204 2.0× 55 0.7× 35 1.1× 15 387
Eric Xueyu Chen Canada 9 187 1.1× 85 0.7× 126 1.3× 93 1.2× 17 0.5× 54 370

Countries citing papers authored by Özge Gümüşay

Since Specialization
Citations

This map shows the geographic impact of Özge Gümüşay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özge Gümüşay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özge Gümüşay more than expected).

Fields of papers citing papers by Özge Gümüşay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özge Gümüşay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özge Gümüşay. The network helps show where Özge Gümüşay may publish in the future.

Co-authorship network of co-authors of Özge Gümüşay

This figure shows the co-authorship network connecting the top 25 collaborators of Özge Gümüşay. A scholar is included among the top collaborators of Özge Gümüşay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özge Gümüşay. Özge Gümüşay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gümüşay, Özge, Laura A. Huppert, Mark Jesus M. Magbanua, et al.. (2023). A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. Breast Cancer Research and Treatment. 203(2). 197–204. 1 indexed citations
2.
Huppert, Laura A., Özge Gümüşay, Damé Idossa, & Hope S. Rugo. (2023). Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer. CA A Cancer Journal for Clinicians. 73(5). 480–515. 96 indexed citations breakdown →
3.
4.
Çetin, Bülent, et al.. (2022). CDK4/6 Inhibitors: Mechanisms of Resistance and Potential Biomarkers of Responsiveness in Breast Cancer. Future Oncology. 18(9). 1143–1157. 17 indexed citations
5.
Magbanua, Mark Jesus M., Özge Gümüşay, Razelle Kurzrock, Laura van ‘t Veer, & Hope S. Rugo. (2022). Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy. Frontiers in Oncology. 12. 802579–802579. 13 indexed citations
6.
Yi̇ği̇t, Serbülent, et al.. (2021). Possible Association of PER2/PER3 Variable Number Tandem Repeat Polymorphism Variants with Susceptibility and Clinical Characteristics in Pancreatic Cancer. Genetic Testing and Molecular Biomarkers. 25(2). 124–130. 3 indexed citations
7.
Çetin, Bülent, et al.. (2021). Optimal Treatment for Patients with Oligometastatic Prostate Cancer. Urologia Internationalis. 106(3). 217–226. 3 indexed citations
8.
Gümüşay, Özge, et al.. (2020). Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology. American Society of Clinical Oncology Educational Book. 40(40). e292–e308. 12 indexed citations
9.
Çetin, Bülent, et al.. (2020). The DNA damaging revolution. Critical Reviews in Oncology/Hematology. 156. 103117–103117. 12 indexed citations
10.
Çetin, Bülent, Özge Gümüşay, Barış Afşar, et al.. (2019). Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib. Journal of Cancer Research and Therapeutics. 17(2). 408–413. 1 indexed citations
11.
Çetin, Bülent, İpek Işık Gönül, Özge Gümüşay, et al.. (2018). Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme. Neuropathology. 38(5). 457–462. 20 indexed citations
12.
Demir, Ayşe Kevser, et al.. (2018). Kemiğin dev hücreli tümörü taklit eden primer hiperparatiroidizme bağlı brown tümörü. SHILAP Revista de lepidopterología.
13.
Kölükçü, Engin, et al.. (2018). Contralateral Testicular Metastasis of Renal Cell Carcinoma: A Case Report. Eurasian Journal of Medicine. 51(3). 310–312. 4 indexed citations
14.
Çetin, Bülent, İpek Işık Gönül, Süleyman Buyukberber, et al.. (2015). The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors. Tumor Biology. 36(11). 8471–8478. 5 indexed citations
15.
Gümüşay, Özge, Bülent Çetin, Mustafa Beneklı, et al.. (2015). Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients. Journal of Cancer Education. 31(2). 308–313. 3 indexed citations
16.
Aydíl, Utku, Müge Akmansu, Özge Gümüşay, et al.. (2015). Comparison of three different concurrent chemoradiation regimens for treatment of laryngeal cancer. European Archives of Oto-Rhino-Laryngology. 273(9). 2795–2803. 5 indexed citations
17.
Özet, Ahmet, Özge Gümüşay, Güldal Yılmaz, et al.. (2015). Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients. Wiener klinische Wochenschrift. 128(1-2). 42–47. 1 indexed citations
18.
19.
Küçüköner, Mehmet, Abdurrahman Işıkdoğan, Özge Gümüşay, et al.. (2012). Oral Etoposide for Platinum-Resistant and Recurrent Epithelial Ovarian Cancer: a Study by the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention. 13(8). 3973–3976. 23 indexed citations
20.
Ma, Kaplan, Abdurrahman Işıkdoğan, Doğan Koca, et al.. (2012). Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study.. Journal of Clinical Oncology. 30(15_suppl). 638–638. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dilara Akhoundova Breakdown of academic impact, for papers by Karel Cwiertka Breakdown of academic impact, for papers by Daniel P. Petro Breakdown of academic impact, for papers by Samia Melaabi Breakdown of academic impact, for papers by Umair Majeed Breakdown of academic impact, for papers by Christa G.M. Gadellaa-van Hooijdonk Breakdown of academic impact, for papers by Rodrigo Ruiz-Soto Breakdown of academic impact, for papers by Lydia Koi Breakdown of academic impact, for papers by Lucia Raimondo Breakdown of academic impact, for papers by Eric Xueyu Chen
Rankless by CCL
2026